M.D. Ph.D. Hoyoung Huh - Director, 10%+ Owner at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Issuer Symbol: AKTX on Nasdaq
All Insider Reports: All Insider Reports

M.D. Ph.D. Hoyoung Huh - trading volume in the past year for Akari Therapeutics Plc

	Shares	%	Avg Price	Total $
Buys	+3,711,951	100%	$0.4041	+$1,499,999
Sells
Net	+3,711,951	100%		+$1,499,999

Holdings reported by M.D. Ph.D. Hoyoung Huh for Akari Therapeutics Plc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
American Depositary Shares representing Ordinary Shares	4,695,854	$5,259,356	$1.12	20 Mar 2025	Direct
Pre-Funded Warrants to purchase ADRs	3,093,293	$1,249,999	$0.4041	16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Series A Warrants (Right to Buy)	892,857	$1,000,000	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy)	892,857	$1,000,000	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares	109,457	$122,592	$1.12	20 Mar 2025	Hannol Ventures LLC
Warrants to purchase ADRs	3,093,293			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Warrants to purchase American Depositary Shares ("ADRs")	618,658			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Stock Option (Right to Buy)	225,000			20 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares

Transactions reported by M.D. Ph.D. Hoyoung Huh for Akari Therapeutics Plc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.